Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. [electronic resource]
Producer: 20150223Description: 890-5 p. digitalISSN:- 1478-3231
- Adult
- Antiviral Agents -- therapeutic use
- Biomarkers -- blood
- Chi-Square Distribution
- Drug Therapy, Combination
- Female
- Gene Frequency
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Heterozygote
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Patient Selection
- Pharmacogenetics
- Phenotype
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Single Nucleotide
- Precision Medicine
- RNA, Viral -- blood
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Time Factors
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.